US Cracks Down on Indian Online Pharmacy for Fentanyl Trafficking

The US has imposed visa restrictions on key figures linked to an Indian online pharmacy involved in selling illicit fentanyl. This move aims to combat the supply of counterfeit pills laced with fentanyl, a drug classified as a Weapon of Mass Destruction, further highlighting US-India efforts to counter illicit drug networks.

US Cracks Down on Indian Online Pharmacy for Fentanyl Trafficking
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The United States has enforced visa restrictions on individuals associated with an Indian online pharmacy, accused of trafficking illicit fentanyl to Americans. The State Department's move targets 13 people linked to KS International Traders, which reportedly sold counterfeit medication laced with the dangerous opioid.

State Department spokesman Tommy Pigott emphasized that KS International Traders profited from trafficking fentanyl, declared a Weapon of Mass Destruction by an executive order under former President Donald Trump. The action, taken under the Immigration and Nationality Act, reflects the commitment of the US and India to tackle entities perpetuating the opioid crisis.

Last year, US sanctions targeted two Indian nationals and an online pharmacy distributing similar counterfeit pills. Recent arrests by Indian authorities of individuals like Satishkumar Hareshbhai Sutaria, linked to trading in fentanyl precursors, underscore ongoing international cooperation against drug trafficking networks.

TRENDING

OPINION / BLOG / INTERVIEW

AI can support rural income growth, but only with infrastructure and policy backing

Digital transformation of humanitarian supply chains could improve trust and sustainability

Quantum machine learning shows promise for adaptive learning, but classrooms are not ready

Developing APEC economies show stronger real capital mobility than advanced peers

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback